About us   Contacts   Links   Information in Russian 
Research programms
2022 year 2021 year 2020 year 2019 year 2018 year 2017 year 2016 year 2015 year 2014 year 2013 year 2012 year 2011 year 2010 year 2009 year 2008 year 2007 year 2006 year 2005 year
Publications

The list of publications in 2022


  1. Salek S., Ionova T., Oliva E.N., et al. The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review. Cancers (Basel). 2022; 14 (23): 6007. doi: 10.3390/cancers14236007.
  2. Ionova T.I., Amdiev A. A., Andrievskikh, et al. Clinical Oncohematology. 2022; 15 (1): 42–53. (In Russ.). DOI: 10.21320/2500-2139-2022-15-1-42-53.
  3. Ionova T.I., Andreevskaya E.A., Babich E.N., et al. Current Quality-of-Life Aspects in Patients with Classical Ph-Negative Myeloproliferative Neoplasms in the Russian Federation: Overview of the Outcomes of the National Observational Program MPN-QoL-2020. Clinical oncohematology. 2022; 15 (2): 176–97. (In Russ.). DOI: 10.21320/2500-2139-2022-15-2-176-197.
  4. Yugay S.V., Krasavina M.A., Tyutrina Yu.A., Nikitina T.P., Elmurzaev A.B., Rykov I.V. The role of the geriatic (G8) health status screening tool in prediction of antitumor therapy complications in elderly patients. Malignant tumours. 2022;12(1):13-20. (In Russ.) https://doi.org/10.18027/2224-5057-2022-12-1-13-20.
  5. Nikitina T.P., Ionova T.I. Modern issues of quality of life research in pediatrics. Pediatric Bulletin of the South Ural 2022; 1: 4–18. (In Russ.) DOI: 10.34710/Chel.2022.94.65.002.
  6. Ionova T.I., Vinogradova O.Yu., Kochkareva Yu.B., et al. Quality of Life and Efficacy of Triplet IxaRd Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Multi-Center Pilot Real-World Study. Clinical oncohematology. 2022; 15 (3): 240–52. (In Russ). DOI: 10.21320/2500-2139-2022-15-3-240-252.
  7. Melnichenko V.Ya., Ionova T.I., Nikitina T.P., et al. Ñlinical and patient-reported outcomes of autologous hematopoietic stem cell transplantation (AHSCT) in patients with multiple sclerosis: single center experience. Acta Scientific Neurology. 2022; 5 (5): 9–19. DOI: 10.31080/ASNE.2022.05.0496
  8. Ionova T.I., Polischuk L.O., Nikitina T.P., Vetshev F.P. Linguistic and cultural adaptation of the Russian version of the Otago Condition-Specific Questionnaire (Gallstone disease — pretreatment). Bulletin of the Multinational Center for Quality of Life Research. 2022; 39–40: 70–78.
  9. Shevchenko Yu.L., Ionova T.I., Melnichenko V.Ya., Porfirieva N.M., Nikitina T.P. Quality of life and psychological problems in patients with oncohematological malignancies during pandemic COVID-19: the results of a single center study. Bulletin of the Multinational Center for Quality of Life Research. 2022; 39–40: 19–27.
  10. Nikitina T. P., Melnichenko V. Ya., Ionova T. I. Quality of life assessment in clinical practice: state of the art and perspectives. Bulletin of the Multinational Center for Quality of Life Research. 2022; 39–40: 7–18.
  11. Porfirieva N. M., Nikitina T. P., Ionova T. I. Assessment of quality of life and cognitive impairment in older adults. Bulletin of the Multinational Center for Quality of Life Research. 2022; 39–40: 83–96.
  12. Ionova T.I., Frolova E.V., Ovakimyan K.V., Mkhitaryan E.A., Tkacheva O.N., Porfirieva N.M., Nikitina T.P. Linguistic and cultural adaptation of the Russian version of general practitioner assessment of cognition questionnaire ? GPCOG in elderly and senile patients at the primary care level. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2022;122(12):117?127. (In Russ., In Engl.). https://doi.org/10.17116/jnevro2022122121117.
  13. Shevchenko YU.L., Ionova T.I., Melnichenko V.YA., Nikitina T.P. Mental health and professional burnout among medical workers providing care to oncohematological patients in the context of the COVID-19 pandemic. Gematologiya and Transfuziologiia. 2022; Application 67 (2): 130. (In Russ.).
  14. Shevchenko YU.L., Ionova T.I., Melnichenko V.YA., Nikitina T.P. Actual aspects of the quality of life in oncohematological patients in the context of the COVID-19 pandemic. Gematologiya and Transfuziologiia. 2022; Application 67 (2): 62. (In Russ).
  15. Ionova T.I., Vinogradova O.Yu., Markova E.E., et al. Quality of life and clinical outcomes in adult patients with chronic immune thrombocytopenia (cITP) during treatment with romiplostim in a real-world setting. HemaSphere, 2022; 6 (S3): 2178-2179. DOI: 10.1097/01.HS9.0000852060.15771.ed.
  16. Ionova T., Vinogradova O., Kochkareva Yu., et al. Quality of life and clinical outcomes in patients with relapsed/refractory multiple myeloma (RRMM) treated with ixazomib-lenalidomide-dexamethasone (IRd): results of a real-world evidence study. HemaSphere, 2022; 6 (S3): 1892-1893. DOI: 10.1097/01.HS9.0000850916.45282.84.
  17. Ionova T.I., Andreevskaya E.A., Babich E.N., et al. Quality of life and unmet needs among Ph-negative myeloproliferative neoplasm patients: results of the nationwide survey. HemaSphere, 2022; 6: (S3): 1605-1606. DOI: 10.1097/01.HS9.0000849752.72405.e9.
  18. Oliva E.N., Salek S., Laane E., Ionova T. Patient-reported outcomes in myeloproliferative neoplasms in clinical trials: a systematic review. HemaSphere, 2022; 6: (S3): 1586-1587. DOI: 10.1097/01.HS9.0000849676.43743.28
  19. Pemberton-Whiteley Z., Nier S., Geissler J.,  Ionova T.I., et al. Differences in Experiences Reported By Patients with Acute and Chronic Leukemia: A Global Survey. Blood. 2022. 140 (Supplement 1): 13273–13275. https://doi.org/10.1182/blood-2022-163466
  20. Pemberton-Whiteley Z., Nier S.,  Ionova T.I., et al. Experiences and Views of Leukemia Patients: A Global Survey. Blood. 2022. 140 (Supplement 1): 5258–5259. https://doi.org/10.1182/blood-2022-163309.

© Ñîçäàíèå ñàéòîâ

Ïîñëåäíåå îáíîâëåíèå (last update): 27-04-2024








ßíäåêñ öèòèðîâàíèÿ